Geode Capital Management’s 20/20 Biolabs AIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.8K Buy
54,493
+5,352
+11% +$2.76K ﹤0.01% 4299
2026
Q2
$27K Buy
+49,141
New +$61.7K ﹤0.01% 4345

Other funds holding AIDX

Geode Capital Management's AIDX Position: Q3 2026 in Review

Geode Capital Management increased its 20/20 Biolabs (AIDX) stake by 11% in Q3 2026, buying an estimated $2.76K and bringing the position to 54,493 shares worth $23.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4299.

Geode Capital Management first reported a position in AIDX in Q2 2026 and has held it in 2 quarters since. The position peaked at $27K in Q2 2026. 16 funds tracked by Wall St. Rank hold AIDX as of Q3 2026.

  • Geode Capital Management held 54,493 shares of 20/20 Biolabs worth $23.8K as of Q3 2026.
  • Geode Capital Management bought 5,352 20/20 Biolabs shares in Q3 2026, an estimated $2.76K.
  • 20/20 Biolabs made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4299 holding.
  • Geode Capital Management first reported a position in 20/20 Biolabs in Q2 2026 and has held it in 2 quarters since.
  • Geode Capital Management's 20/20 Biolabs position peaked at $27K in Q2 2026.
  • 16 funds tracked by Wall St. Rank held 20/20 Biolabs as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.